{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:23:32Z","timestamp":1790015012090,"version":"4.0.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s11095-025-03817-3","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T14:09:05Z","timestamp":1737554945000},"page":"79-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prediction Trough Concentrations of Valproic Acid Among Chinese Adult Patients with Epilepsy Using Machine Learning Techniques"],"prefix":"10.1007","volume":"42","author":[{"given":"Nannan","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongshi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"issue":"4 Suppl 1","key":"3817_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5698\/1535-7597.18.4s1.1","volume":"18","author":"DG Vossler","year":"2018","unstructured":"Vossler DG, Weingarten M, Gidal BE. Summary of antiepileptic drugs available in the United States of America: working toward a world without epilepsy. Epilepsy Curr. 2018;18(4 Suppl 1):1\u201326.","journal-title":"Epilepsy Curr"},{"issue":"9","key":"3817_CR2","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s11064-014-1241-2","volume":"39","author":"S Chen","year":"2014","unstructured":"Chen S, Wu H, Klebe D, et al. Valproic acid: a new candidate of therapeutic application for the acute central nervous system injuries. Neurochem Res. 2014;39(9):1621\u201333.","journal-title":"Neurochem Res"},{"key":"3817_CR3","doi-asserted-by":"crossref","first-page":"1037239","DOI":"10.3389\/fphar.2022.1037239","volume":"13","author":"X Shen","year":"2022","unstructured":"Shen X, Chen X, Lu J, et al. Pharmacogenetics-based population pharmacokinetic analysis and dose optimization of valproic acid in Chinese southern children with epilepsy: effect of ABCB1 gene polymorphism. Front Pharmacol. 2022;13:1037239.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3817_CR4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/dta.3362","volume":"15","author":"JP Pascali","year":"2023","unstructured":"Pascali JP, Giorgetti A, Barone R, et al. Valproic acid determination by liquid chromatography coupled to mass spectrometry (LC-MS\/MS) in whole blood for forensic purposes. Drug Test Anal. 2023;15(1):128\u201333.","journal-title":"Drug Test Anal"},{"issue":"8","key":"3817_CR5","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00228-018-2440-6","volume":"74","author":"S Mei","year":"2018","unstructured":"Mei S, Feng W, Zhu L, et al. Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model. Eur J Clin Pharmacol. 2018;74(8):1029\u201336.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"3817_CR6","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/jaoacint\/qsac146","volume":"106","author":"A el Orche","year":"2023","unstructured":"el Orche A, Cheikh A, Johnson JB, et al. A novel approach for therapeutic drug monitoring of valproic acid using FT-IR spectroscopy and nonlinear support vector regression. J AOAC Int. 2023;106(4):1070\u20136.","journal-title":"J AOAC Int"},{"issue":"5","key":"3817_CR7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/17512433.2022.2075849","volume":"15","author":"YN Zang","year":"2022","unstructured":"Zang YN, Guo W, Dong F, et al. Published population pharmacokinetic models of valproic acid in adult patients: a systematic review and external validation in a Chinese sample of inpatients with bipolar disorder. Expert Rev Clin Pharmacol. 2022;15(5):621\u201335.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1\u201302","key":"3817_CR8","first-page":"9","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement HW, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51(1\u201302):9\u201362.","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"3817_CR9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/FTD.0000000000000100","volume":"37","author":"WW Lin","year":"2015","unstructured":"Lin WW, Jiao Z, Wang CL, et al. Population pharmacokinetics of valproic acid in adult Chinese epileptic patients and its application in an individualized dosage regimen. Ther Drug Monit. 2015;37(1):76\u201383.","journal-title":"Ther Drug Monit"},{"key":"3817_CR10","doi-asserted-by":"crossref","first-page":"1228641","DOI":"10.3389\/fphar.2023.1228641","volume":"14","author":"L Zhang","year":"2023","unstructured":"Zhang L, Liu M, Qin W, et al. Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study. Front Pharmacol. 2023;14:1228641.","journal-title":"Front Pharmacol"},{"issue":"8","key":"3817_CR11","doi-asserted-by":"crossref","first-page":"300060520952281","DOI":"10.1177\/0300060520952281","volume":"48","author":"J Guo","year":"2020","unstructured":"Guo J, Huo Y, Li F, et al. Impact of gender, albumin, and CYP2C19 polymorphisms on valproic acid in Chinese patients: a population pharmacokinetic model. J Int Med Res. 2020;48(8):300060520952281.","journal-title":"J Int Med Res"},{"issue":"7","key":"3817_CR12","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00228-020-03080-y","volume":"77","author":"X Gu","year":"2021","unstructured":"Gu X, Zhu M, Sheng C, et al. Population pharmacokinetics of unbound valproic acid in pediatric epilepsy patients in China: a protein binding model. Eur J Clin Pharmacol. 2021;77(7):999\u20131009.","journal-title":"Eur J Clin Pharmacol"},{"key":"3817_CR13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejps.2018.06.033","volume":"122","author":"S Xu","year":"2018","unstructured":"Xu S, Chen Y, Zhao M, et al. Population pharmacokinetics of valproic acid in epileptic children: effects of clinical and genetic factors. Eur J Pharm Sci. 2018;122:170\u20138.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"3817_CR14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/00498254.2019.1601791","volume":"50","author":"D Wang","year":"2020","unstructured":"Wang D, Chen X, Xu H, et al. Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese pediatric hematopoietic stem cell transplantation patients. Xenobiotica. 2020;50(2):178\u201385.","journal-title":"Xenobiotica"},{"key":"3817_CR15","doi-asserted-by":"crossref","first-page":"942129","DOI":"10.3389\/fphar.2022.942129","volume":"13","author":"Q Huang","year":"2022","unstructured":"Huang Q, Lin X, Wang Y, et al. Tacrolimus pharmacokinetics in pediatric nephrotic syndrome: a combination of population pharmacokinetic modelling and machine learning approaches to improve individual prediction. Front Pharmacol. 2022;13:942129.","journal-title":"Front Pharmacol"},{"key":"3817_CR16","doi-asserted-by":"crossref","unstructured":"Chen Y, Liu R, Ma P, et al. A real-time plasma concentration prediction model for voriconazole in elderly patients via machine learning combined with population pharmacokinetics. Authorea Preprints.\u00a02024.","DOI":"10.22541\/au.171782996.66229530\/v1"},{"issue":"7","key":"3817_CR17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jval.2019.02.012","volume":"22","author":"P Doupe","year":"2019","unstructured":"Doupe P, Faghmous J, Basu S. Machine learning for health services researchers. Value Health. 2019;22(7):808\u201315.","journal-title":"Value Health"},{"issue":"4","key":"3817_CR18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s11095-022-03252-8","volume":"39","author":"M Bououda","year":"2022","unstructured":"Bououda M, Uster DW, Sidorov E, et al. A machine learning approach to predict Interdose vancomycin exposure. Pharm Res. 2022;39(4):721\u201331.","journal-title":"Pharm Res"},{"key":"3817_CR19","doi-asserted-by":"crossref","first-page":"105578","DOI":"10.1016\/j.phrs.2021.105578","volume":"167","author":"JB Woillard","year":"2021","unstructured":"Woillard JB, Labriffe M, Pr\u00e9maud A, et al. Estimation of drug exposure by machine learning based on simulations from published pharmacokinetic models: the example of tacrolimus. Pharmacol Res. 2021;167:105578.","journal-title":"Pharmacol Res"},{"key":"3817_CR20","doi-asserted-by":"crossref","first-page":"1289673","DOI":"10.3389\/fphar.2024.1289673","volume":"15","author":"R Fu","year":"2024","unstructured":"Fu R, Hao X, Yu J, et al. Machine learning-based prediction of sertraline concentration in patients with depression through therapeutic drug monitoring. Front Pharmacol. 2024;15:1289673.","journal-title":"Front Pharmacol"},{"key":"3817_CR21","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1111\/bcp.16112","volume":"90","author":"YW Chen","year":"2024","unstructured":"Chen YW, Lin XK, Huang C, et al. Vancomycin trough concentration in adult patients with periprosthetic joint infection: a machine learning-based covariate model. Br J Clin Pharmacol. 2024;90:2188\u201399.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"3817_CR22","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1038\/s41598-021-85157-x","volume":"11","author":"X Zhu","year":"2021","unstructured":"Zhu X, Huang W, Lu H, et al. A machine learning approach to personalized dose adjustment of lamotrigine using noninvasive clinical parameters. Sci Rep. 2021;11(1):5568.","journal-title":"Sci Rep"},{"issue":"6","key":"3817_CR23","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/cpt.2577","volume":"111","author":"H Soeorg","year":"2022","unstructured":"Soeorg H, Sverrisd\u00f3ttir E, Andersen M, et al. Artificial neural network vs. pharmacometric model for population prediction of plasma concentration in real-world data: a case study on valproic acid. Clin Pharmacol Ther. 2022;111(6):1278\u201385.","journal-title":"Clin Pharmacol Ther"},{"key":"3817_CR24","doi-asserted-by":"crossref","first-page":"890221","DOI":"10.3389\/fphar.2022.890221","volume":"13","author":"P Zheng","year":"2022","unstructured":"Zheng P, Yu Z, Mo L, et al. An individualized medication model of sodium valproate for patients with bipolar disorder based on machine learning and deep learning techniques. Front Pharmacol. 2022;13:890221.","journal-title":"Front Pharmacol"},{"key":"3817_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jad.2023.11.047","volume":"347","author":"CW Hsu","year":"2024","unstructured":"Hsu CW, Lai EC, Chen YB, et al. Valproic acid monitoring: serum prediction using a machine learning framework from multicenter real-world data. J Affect Disord. 2024;347:85\u201391.","journal-title":"J Affect Disord"},{"key":"3817_CR26","doi-asserted-by":"crossref","first-page":"106506","DOI":"10.1016\/j.ejps.2023.106506","volume":"188","author":"L Cheng","year":"2023","unstructured":"Cheng L, Zhao Y, Liang Z, et al. Prediction of plasma trough concentration of voriconazole in adult patients using machine learning. Eur J Pharm Sci. 2023;188:106506.","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"3817_CR27","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1109\/TNNLS.2019.2920864","volume":"31","author":"Y Wang","year":"2020","unstructured":"Wang Y, Pan Z, Pan Y. A training data set cleaning method by classification ability ranking for the k-nearest neighbor classifier. IEEE Trans Neural Netw Learn Syst. 2020;31(5):1544\u201356.","journal-title":"IEEE Trans Neural Netw Learn Syst"},{"issue":"8","key":"3817_CR28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s40262-023-01265-z","volume":"62","author":"BH Tang","year":"2023","unstructured":"Tang BH, Zhang JY, Allegaert K, et al. Use of machine learning for dosage individualization of vancomycin in neonates. Clin Pharmacokinet. 2023;62(8):1105\u201316.","journal-title":"Clin Pharmacokinet"},{"key":"3817_CR29","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2147\/DDDT.S299037","volume":"15","author":"X Huang","year":"2021","unstructured":"Huang X, Yu Z, Bu S, et al. An ensemble model for prediction of vancomycin trough concentrations in pediatric patients. Drug Des Devel Ther. 2021;15:1549\u201359.","journal-title":"Drug Des Devel Ther"},{"key":"3817_CR30","doi-asserted-by":"crossref","first-page":"154784","DOI":"10.1016\/j.jcrc.2024.154784","volume":"82","author":"MS Tootooni","year":"2024","unstructured":"Tootooni MS, Barreto EF, Wutthisirisart P, et al. Determining steady-state trough range in vancomycin drug dosing using machine learning. J Crit Care. 2024;82:154784.","journal-title":"J Crit Care"},{"issue":"1","key":"3817_CR31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12911-022-01970-y","volume":"22","author":"J Verhaeghe","year":"2022","unstructured":"Verhaeghe J, Dhaese SAM, de Corte T, et al. Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients. BMC Med Inform Decis Mak. 2022;22(1):224.","journal-title":"BMC Med Inform Decis Mak"},{"key":"3817_CR32","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, et al. Scikit-learn: machine learning in Python. J Mach Learn Res. 2011;12:2825\u201330.","journal-title":"J Mach Learn Res"},{"key":"3817_CR33","unstructured":"Dorogush AV, Ershov V, Gulin A. CatBoost: gradient boosting with categorical features support. arXiv preprint arXiv:181011363. 2018."},{"key":"3817_CR34","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C. Xgboost: a scalable tree boosting system; proceedings of the Proceedings of the 22nd acm sigkdd international conference on knowledge discovery and data mining, F. 2016[C].","DOI":"10.1145\/2939672.2939785"},{"key":"3817_CR35","doi-asserted-by":"crossref","first-page":"116890","DOI":"10.1016\/j.jenvman.2022.116890","volume":"327","author":"A el Bilali","year":"2023","unstructured":"el Bilali A, Abdeslam T, Ayoub N, et al. An interpretable machine learning approach based on DNN, SVR, extra tree, and XGBoost models for predicting daily pan evaporation. J Environ Manage. 2023;327:116890.","journal-title":"J Environ Manage"},{"issue":"10","key":"3817_CR36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41551-018-0304-0","volume":"2","author":"SM Lundberg","year":"2018","unstructured":"Lundberg SM, Nair B, Vavilala MS, et al. Explainable machine-learning predictions for the prevention of hypoxaemia during surgery. Nat Biomed Eng. 2018;2(10):749\u201360.","journal-title":"Nat Biomed Eng"},{"key":"3817_CR37","unstructured":"Lundberg S. A unified approach to interpreting model predictions. arXiv preprint arXiv:170507874. 2017."},{"issue":"3","key":"3817_CR38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen P, Gommers R, Oliphant TE, et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods. 2020;17(3):261\u201372.","journal-title":"Nat Methods"},{"issue":"03","key":"3817_CR39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter JD. Matplotlib: a 2D graphics environment. Comput Sci Eng. 2007;9(03):90\u20135.","journal-title":"Comput Sci Eng"},{"issue":"60","key":"3817_CR40","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.21105\/joss.03021","volume":"6","author":"ML Waskom","year":"2021","unstructured":"Waskom ML. Seaborn: statistical data visualization. J Open Source Softw. 2021;6(60):3021.","journal-title":"J Open Source Softw"},{"key":"3817_CR41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/978-3-319-77932-4_37","volume":"1065","author":"A Alonso-Betanzos","year":"2018","unstructured":"Alonso-Betanzos A, Bol\u00f3n-Canedo V. Big-data analysis, cluster analysis, and machine-learning approaches. Adv Exp Med Biol. 2018;1065:607\u201326.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"3817_CR42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1109\/TIT.1968.1054102","volume":"14","author":"G Hughes","year":"1968","unstructured":"Hughes G. On the mean accuracy of statistical pattern recognizers. IEEE Trans Inf Theory. 1968;14(1):55\u201363.","journal-title":"IEEE Trans Inf Theory"},{"issue":"2","key":"3817_CR43","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1540-5915.1979.tb00026.x","volume":"10","author":"LE Yelle","year":"1979","unstructured":"Yelle LE. The learning curve: historical review and comprehensive survey. Decis Sci. 1979;10(2):302\u201328.","journal-title":"Decis Sci"},{"key":"3817_CR44","doi-asserted-by":"crossref","first-page":"111740","DOI":"10.1016\/j.envres.2021.111740","volume":"202","author":"C Wang","year":"2021","unstructured":"Wang C, Feng L, Qi Y. Explainable deep learning predictions for illness risk of mental disorders in Nanjing, China. Environ Res. 2021;202:111740.","journal-title":"Environ Res"},{"issue":"6","key":"3817_CR45","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.clinthera.2017.04.005","volume":"39","author":"J Methaneethorn","year":"2017","unstructured":"Methaneethorn J. Population pharmacokinetics of valproic acid in patients with Mania: implication for individualized dosing regimens. Clin Ther. 2017;39(6):1171\u201381.","journal-title":"Clin Ther"},{"issue":"3","key":"3817_CR46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00228-021-03246-2","volume":"78","author":"YN Zang","year":"2022","unstructured":"Zang YN, Guo W, Niu MX, et al. Population pharmacokinetics of valproic acid in adult Chinese patients with bipolar disorder. Eur J Clin Pharmacol. 2022;78(3):405\u201318.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"3817_CR47","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1381612825666190329145428","volume":"25","author":"HL Guo","year":"2019","unstructured":"Guo HL, Jing X, Sun JY, et al. Valproic acid and the liver injury in patients with epilepsy: an update. Curr Pharm Des. 2019;25(3):343\u201351.","journal-title":"Curr Pharm Des"},{"issue":"6","key":"3817_CR48","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3904\/kjim.2020.410","volume":"35","author":"JH Park","year":"2020","unstructured":"Park JH, Jo YI, Lee JH. Renal effects of uric acid: hyperuricemia and hypouricemia. Korean J Intern Med. 2020;35(6):1291\u2013304.","journal-title":"Korean J Intern Med"},{"issue":"3","key":"3817_CR49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40262-014-0212-8","volume":"54","author":"J Ding","year":"2015","unstructured":"Ding J, Wang Y, Lin W, et al. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation. Clin Pharmacokinet. 2015;54(3):305\u201317.","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"3817_CR50","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s40262-022-01171-w","volume":"61","author":"K Lin","year":"2022","unstructured":"Lin K, Cao VFS, Au C, et al. Clinical pharmacokinetic monitoring of free valproic acid levels: a systematic review. Clin Pharmacokinet. 2022;61(10):1345\u201363.","journal-title":"Clin Pharmacokinet"},{"key":"3817_CR51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2019.04.019","volume":"98","author":"R Kumar","year":"2019","unstructured":"Kumar R, Vidaurre J, Gedela S. Valproic acid-induced coagulopathy. Pediatr Neurol. 2019;98:25\u201330.","journal-title":"Pediatr Neurol"},{"issue":"7","key":"3817_CR52","first-page":"775","volume":"44","author":"H Ma","year":"2019","unstructured":"Ma H, Zhu W, Wang C, et al. Association of valproic acid and 2-propyl-4-pentenoic acid concentrations with adverse reaction in 254 Chinese patients with epilepsy. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019;44(7):775\u201383.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"7","key":"3817_CR53","first-page":"782","volume":"45","author":"X Yang","year":"2020","unstructured":"Yang X, Wang P, Pan J, et al. Valproic acid concentration and biochemical indexes in epilepsy outpatients during monotherapy or combination therapy. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020;45(7):782\u20139.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"4","key":"3817_CR54","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3390\/pharmaceutics14040811","volume":"14","author":"P Teixeira-da-Silva","year":"2022","unstructured":"Teixeira-da-Silva P, P\u00e9rez-Blanco JS, Santos-Buelga D, et al. Population pharmacokinetics of valproic acid in pediatric and adult Caucasian patients. Pharmaceutics. 2022;14(4):811.","journal-title":"Pharmaceutics"},{"issue":"2","key":"3817_CR55","first-page":"537","volume":"33","author":"Y Wang","year":"2020","unstructured":"Wang Y, Hu W, Li Z. Influence of age and co-medication on the concentration and efficacy of valproic acid in Chinese epilepsy children. Pak J Pharm Sci. 2020;33(2):537\u201342.","journal-title":"Pak J Pharm Sci"},{"issue":"11","key":"3817_CR56","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s40262-013-0087-0","volume":"52","author":"PN Patsalos","year":"2013","unstructured":"Patsalos PN. Drug interactions with the newer antiepileptic drugs (AEDs)\u2013part 1: pharmacokinetic and pharmacodynamic interactions between AEDs. Clin Pharmacokinet. 2013;52(11):927\u201366.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"3817_CR57","first-page":"702","volume":"15","author":"T Aghebati","year":"2012","unstructured":"Aghebati T, Foroughipour M, Azarpazhooh MR, et al. Relationship between patient demographic characteristics, valproic acid dosage and clearance in adult Iranian patients. Iran J Basic Med Sci. 2012;15(2):702\u20138.","journal-title":"Iran J Basic Med Sci"},{"issue":"4","key":"3817_CR58","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s11096-019-00864-w","volume":"41","author":"S Alqahtani","year":"2019","unstructured":"Alqahtani S, Alandas N, Alsultan A. Estimation of apparent clearance of valproic acid in adult Saudi patients. Int J Clin Pharm. 2019;41(4):1056\u201361.","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"3817_CR59","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/bcp.13510","volume":"84","author":"J Methaneethorn","year":"2018","unstructured":"Methaneethorn J. A systematic review of population pharmacokinetics of valproic acid. Br J Clin Pharmacol. 2018;84(5):816\u201334.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"3817_CR60","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","volume":"23","author":"Y Ghodke-Puranik","year":"2013","unstructured":"Ghodke-Puranik Y, Thorn CF, Lamba JK, et al. Valproic acid pathway: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics. 2013;23(4):236\u201341.","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"3817_CR61","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/03602530903209288","volume":"42","author":"MH Court","year":"2010","unstructured":"Court MH. Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system. Drug Metab Rev. 2010;42(1):209\u201324.","journal-title":"Drug Metab Rev"},{"issue":"9","key":"3817_CR62","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/bdd.636","volume":"29","author":"T Correa","year":"2008","unstructured":"Correa T, Rodr\u00edguez I, Romano S. Population pharmacokinetics of valproate in Mexican children with epilepsy. Biopharm Drug Dispos. 2008;29(9):511\u201320.","journal-title":"Biopharm Drug Dispos"},{"key":"3817_CR63","doi-asserted-by":"crossref","first-page":"101004","DOI":"10.1016\/j.dmpk.2024.101004","volume":"56","author":"M Uno","year":"2024","unstructured":"Uno M, Nakamaru Y, Yamashita F. Application of machine learning techniques in population pharmacokinetics\/pharmacodynamics modeling. Drug Metab Pharmacokinet. 2024;56:101004.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"5","key":"3817_CR64","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3390\/pharmaceutics14051023","volume":"14","author":"S Lee","year":"2022","unstructured":"Lee S, Song M, Han J, et al. Application of machine learning classification to improve the performance of vancomycin therapeutic drug monitoring. Pharmaceutics. 2022;14(5):1023.","journal-title":"Pharmaceutics"},{"issue":"4","key":"3817_CR65","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jphs.2022.02.005","volume":"148","author":"T Matsuzaki","year":"2022","unstructured":"Matsuzaki T, Kato Y, Mizoguchi H, et al. A machine learning model that emulates experts\u2019 decision making in vancomycin initial dose planning. J Pharmacol Sci. 2022;148(4):358\u201363.","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"3817_CR66","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s42979-021-00592-x","volume":"2","author":"IH Sarker","year":"2021","unstructured":"Sarker IH. Machine learning: algorithms, real-world applications and research directions. SN Comput Sci. 2021;2(3):160.","journal-title":"SN Comput Sci"},{"issue":"8","key":"3817_CR67","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3390\/polym16081049","volume":"16","author":"MJ Uddin","year":"2024","unstructured":"Uddin MJ, Fan J. Interpretable machine learning framework to predict the glass transition temperature of polymers. Polymers (Basel). 2024;16(8):1049.","journal-title":"Polymers (Basel)"},{"key":"3817_CR68","doi-asserted-by":"crossref","first-page":"100508","DOI":"10.1016\/j.ijcip.2022.100508","volume":"37","author":"SH Majidi","year":"2022","unstructured":"Majidi SH, Hadayeghparast S, Karimipour H. FDI attack detection using extra trees algorithm and deep learning algorithm-autoencoder in smart grid. Int J Crit Infrastruct Prot. 2022;37:100508.","journal-title":"Int J Crit Infrastruct Prot"},{"issue":"3","key":"3817_CR69","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/ejhpharm-2018-001653","volume":"27","author":"J Methaneethorn","year":"2020","unstructured":"Methaneethorn J, Lohitnavy M. External evaluation of a published population pharmacokinetic model of valproic acid in Thai manic patients. Eur J Hosp Pharm. 2020;27(3):168\u201372.","journal-title":"Eur J Hosp Pharm"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03817-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-025-03817-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03817-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T17:24:38Z","timestamp":1738344278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-025-03817-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3817"],"URL":"https:\/\/doi.org\/10.1007\/s11095-025-03817-3","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving humans was approved by the Hospital Ethics Committee of the Jinshan Hospital affiliated with Fudan University (Approval No. JIEC 2024-S67). The study was performed in accordance with the Declaration of Helsinki. Written informed consent from patients was waived by the Hospital Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}},{"value":"The authors declare no competing interests in this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}